|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
785,947,000 |
Market
Cap: |
130.55(M) |
Last
Volume: |
289,831 |
Avg
Vol: |
832,220 |
52
Week Range: |
$0.0328 - $0.205 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Elite Pharmaceuticals is a pharmaceutical company. Co. owns, licenses or contracts manufacture various products that are being sold commercially, including: bariatric products, which include Phentermine HCl 37.5mg tablets and Phendimetrazine Tartrate 35mg tablets; pain products, which include Naltrexone HCl 50mg tablets and Oxycodone HCl Immediate Release five mg, 10mg, 15mg, 20mg and 30mg tablets; cardiovascular product, which includes Isradipine 2.5mg and five mg capsules; antidepressant product, which includes Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules; and muscle relaxant product, which includes Dantrolene Sodium Capsules 25mg, 50mg and 100mg.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Treppel Jerry |
former Chairman |
|
2016-02-01 |
4 |
S |
$0.34 |
$106,182 |
D/D |
(312,300) |
8,769,469 |
|
- |
|
Treppel Jerry |
former Chairman |
|
2016-01-29 |
4 |
S |
$0.35 |
$40,250 |
D/D |
(115,000) |
9,081,769 |
|
- |
|
Narine Jeenarine |
Director |
|
2015-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000,000 |
12,262,006 |
|
- |
|
Treppel Jerry |
Chairman of Board |
|
2015-11-18 |
4 |
S |
$0.31 |
$7,625 |
D/D |
(25,000) |
9,196,769 |
|
- |
|
Treppel Jerry |
Chairman of Board |
|
2015-11-17 |
4 |
S |
$0.30 |
$7,503 |
D/D |
(25,000) |
9,221,769 |
|
- |
|
Treppel Jerry |
Chairman of Board |
|
2015-11-16 |
4 |
S |
$0.30 |
$15,125 |
D/D |
(50,000) |
9,246,769 |
|
- |
|
Treppel Jerry |
Chairman of Board |
|
2015-11-13 |
4 |
S |
$0.30 |
$15,000 |
D/D |
(50,000) |
9,296,769 |
|
- |
|
Treppel Jerry |
Chairman of Board |
|
2015-11-13 |
4 |
GD |
$0.31 |
$2,325 |
D/D |
7,500 |
9,346,769 |
|
- |
|
Mikah Pharma, Llc |
President & CEO |
|
2015-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
113,954 |
113,954 |
|
- |
|
Narine Jeenarine |
Director |
|
2015-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
398,840 |
398,840 |
|
- |
|
Plassche Douglas |
10% Owner |
|
2015-08-14 |
4 |
A |
$0.23 |
$12,502 |
D/D |
54,169 |
127,263 |
|
- |
|
Hakim Nasrat A |
President & CEO |
|
2015-06-02 |
4 |
OE |
$0.06 |
$171,363 |
I/I |
2,741,801 |
5,311,819 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-05-21 |
4 |
OE |
$0.06 |
$125,000 |
D/D |
2,000,000 |
40,442,232 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-05-05 |
4 |
OE |
$0.06 |
$125,000 |
D/D |
2,000,000 |
38,442,232 |
|
- |
|
Plassche Douglas |
Executive VP of Operations |
|
2015-04-27 |
4 |
S |
$0.24 |
$20,168 |
D/D |
(85,530) |
73,094 |
|
- |
|
Epic Pharma Llc |
10% Owner |
|
2015-04-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(67,659,232) |
0 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-04-23 |
4/A |
A |
$0.00 |
$0 |
D/D |
19,275,135 |
36,442,232 |
|
- |
|
Hakim Nasrat A |
President & CEO |
|
2015-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,570,018 |
2,570,018 |
|
- |
|
Narine Jeenarine |
Director |
|
2015-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,850,089 |
31,269,108 |
|
- |
|
Narine Jeenarine |
Director |
|
2015-04-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(67,659,232) |
0 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
19,275,133 |
55,717,363 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-04-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(67,659,232) |
0 |
|
- |
|
Epic Investments, Llc |
10% Owner |
|
2015-04-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,659,232) |
0 |
|
- |
|
Nigalaye Ashok G |
Director |
|
2015-03-05 |
4 |
A |
$0.34 |
$19,998 |
D/D |
58,475 |
17,167,097 |
|
- |
|
Narine Jeenarine |
Director |
|
2015-03-05 |
4 |
A |
$0.34 |
$19,998 |
D/D |
58,475 |
5,568,930 |
|
- |
|
86 Records found
|
|
Page 3 of 4 |
|
|